Skip to main content

Table 3 Overall survival of miRNA that target YOD1 in PAAD

From: YOD1 serves as a potential prognostic biomarker for pancreatic cancer

miRNA Low expression High expression Prognose P-value HR
hsa-mir-675 n = 62 n = 116 N/A 0.053 1.54 (0.99–2.4)
hsa-mir-150 n = 83 n = 95 N/A 0.095 0.71 (0.47–1.06)
hsa-mir-202 n = 50 n = 128 N/A 0.19 0.75 (0.49–1.16)
hsa-mir-1468 n = 118 n = 60 Favorable 0.02 0.59 (0.37–0.92)
hsa-mir-139 n = 133 n = 45 Favorable 0.0047 0.46 (0.26–0.8)
hsa-mir-140 n = 96 n = 82 Favorable 0.017 0.6 (0.39–0.92)
hsa-mir-218 n = 50 n = 128 Favorable 0.0038 0.53 (0.35–0.82)
hsa-mir-9 n = 119 n = 59 Favorable 0.038 0.61 (0.39–0.98)
hsa-mir-342 n = 119 n = 59 Favorable 0.0013 0.45 (0.27–0.74)
hsa-mir-375 n = 93 n = 85 Favorable 0.012 0.59 (0.39–0.9)
hsa-mir-500a n = 84 n = 94 Favorable 0.0088 0.58 (0.39–0.88)
hsa-mir-433 n = 116 n = 62 N/A 0.069 0.66 (0.43–1.04)